أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

i-care pharma distributors pty ltd - ocriplasmin -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

i-care pharma distributors pty ltd - ocriplasmin, quantity: 1.25 mg/ml - injection, solution - excipient ingredients: mannitol; citric acid monohydrate; sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - jetrea rtu is indicated in adults for the treatment of vitreomacular traction (vmt), including when associated with macular hole of diameter less than or equal to 400 microns.

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - cyanocobalamin - solution for injection - 0.05 %w/v - antianemic preparations - bovine, canine, caprine, equine - food, feline, ovine, porcine - vitamins & minerals

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - cyanocobalamin - solution for injection - 0.05 percent weight/volume - antianemic preparations - cats, cattle, dogs, goats, horses, pigs, sheep - vitamins and minerals

المملكة المتحدة - الإنجليزية - VMD (Veterinary Medicines Directorate)

norbrook laboratories limited - cyanocobalamin - solution for injection - vitamin - cattle, horses, pigs, sheep

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - faricimab, quantity: 120 mg/ml - injection, solution - excipient ingredients: histidine; acetic acid; methionine; sodium chloride; sucrose; polysorbate 20; water for injections - vabysmo is indicated for the treatment of:,- neovascular (wet) age-related macular degeneration (namd),- diabetic macular oedema (dmo).

كندا - الإنجليزية - Health Canada

bausch & lomb inc - ganciclovir - implant - 4.5mg - ganciclovir 4.5mg - nucleosides and nucleotides

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

allergan, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - dexamethasone 0.7 mg - ozurdex ®   (dexamethasone intravitreal implant) is indicated for the treatment of macular edema following branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo). ozurdex ®   is indicated for the treatment of non-infectious uveitis affecting the posterior segment of the eye. ozurdex ®   is indicated for the treatment of diabetic macular edema.   ozurdex ®   (dexamethasone intravitreal implant) is contraindicated in patients with active or suspected ocular or periocular infections including most viral diseases of the cornea and conjunctiva, including active epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella, mycobacterial infections, and fungal diseases.  ozurdex ® is contraindicated in patients with glaucoma, who have cup to disc ratios of greater than 0.8. ozurdex ® is contraindicated in patients whose posterior lens capsule is torn or ruptured because of the risk of migration into the anterior chamber. laser posterior capsulotomy in pseudophakic pati

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

alimera sciences, inc. - fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m) - fluocinolone acetonide 0.19 mg - iluvien® (fluocinolone acetonide intravitreal implant) 0.19 mg is indicated for the treatment of diabetic macular edema (dme) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure. iluvien is contraindicated in patients with active or suspected ocular or periocular infections including most viral disease of the cornea and conjunctiva including active epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella, mycobacterial infections and fungal diseases. iluvien is contraindicated in patients with glaucoma, who have cup to disc ratios of greater than 0.8. iluvien is contraindicated in patients with known hypersensitivity to any components of this product. pregnancy category c there are no adequate and well-controlled studies of iluvien in pregnant women. animal reproduction studies have not been conducted with fluocinolone acetonide. corticosteroids have been shown to be teratogenic in labor